Emmaus Life Sciences (EMMA) director files initial Form 3 ownership

Rhea-AI Filing Summary

Emmaus Life Sciences, Inc. director Du Henry Huy filed an initial Form 3 reporting his status as a director of the company. The filing shows no reportable transactions, no reported common stock holdings, and no derivative securities positions, with all transaction and holding counts recorded as zero.

Key Figures

Buy transactions: 0 Sell transactions: 0 Net shares bought or sold: 0 shares +2 more

5 metrics

Buy transactions 0 Form 3 transactionSummary buyCount

Sell transactions 0 Form 3 transactionSummary sellCount

Net shares bought or sold 0 shares Form 3 transactionSummary netBuySellShares

Holding entries 0 Form 3 transactionSummary holdingEntries

Derivative transactions 0 Form 3 transactionSummary derivativeTransactionCount

Key Terms

Form 3, reportingPersons, transactionSummary, derivativeSummary

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [ { "name": "DU HENRY HUY""

transactionSummary financial

""transactionSummary": { "buyCount": 0, "sellCount": 0"

derivativeSummary financial

""derivativeSummary": [],"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

DU HENRY HUY

(Last) (First) (Middle)

21250 HAWTHORNE BLVD

SUITE 800

(Street)

TORRANCE CALIFORNIA 90503

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/16/2026

3. Issuer Name and Ticker or Trading Symbol
Emmaus Life Sciences, Inc. [ EMMA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Henry H Du	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Emmaus Life Sciences (EMMA) Form 3 filing report for Du Henry Huy?

The Form 3 for Emmaus Life Sciences (EMMA) reports that Du Henry Huy is a director of the company. The filing shows no reportable transactions, no common stock holdings, and no derivative securities positions, with all summarized transaction and holding counts listed as zero.

Does the Emmaus Life Sciences (EMMA) Form 3 show any insider share purchases or sales?

No, the Form 3 for Emmaus Life Sciences (EMMA) shows no insider share purchases or sales by Du Henry Huy. The transaction summary lists buyCount, sellCount, acquireCount, disposeCount, and netBuySellShares all as zero, indicating no reportable trading activity in this filing.

Are any derivative securities reported in the Emmaus Life Sciences (EMMA) Form 3?

No derivative securities are reported in the Emmaus Life Sciences (EMMA) Form 3 for Du Henry Huy. The derivativeSummary array is empty, and derivativeTransactionCount and exerciseCount are both zero, indicating no options, warrants, or other derivatives are disclosed in this filing snapshot.

What is the insider role of Du Henry Huy at Emmaus Life Sciences (EMMA) according to the Form 3?

According to the Form 3, Du Henry Huy is identified as a director of Emmaus Life Sciences (EMMA). The filing flags him as a director, with no officer role, no ten percent owner status, and no other listed insider capacity in the structured data provided.

Does the Emmaus Life Sciences (EMMA) Form 3 indicate any existing holdings for Du Henry Huy?

The Emmaus Life Sciences (EMMA) Form 3 shows no existing reportable holdings for Du Henry Huy. The transactionSummary indicates holdingEntries as zero, and there are no common stock or derivative positions listed, suggesting no reportable ownership data in this particular filing extract.